| Literature DB >> 31624125 |
Wenjie Huang1, Zhe Liu2, Fan Yang1, Huan Zhou3, Xin Yong1, Xiaoyu Yang4, Yifei Zhou1, Lijia Xue5, Yihong Zhang1, Dingdong Liu1, Wentong Meng2, Wenming Zhang1,6, Xiaohu Zhang1,6, Xiaofei Shen1, Qingxiang Sun1, Li Li7, Cong Ma4, Yuquan Wei1, Daniel D Billadeau8, Xianming Mo2, Da Jia9.
Abstract
Pontocerebellar hypoplasia (PCH) is a group of neurological disorders that affect the development of the brain, in particular, the pons and cerebellum. Homozygous mutations of TBC1D23 have been found recently to lead to PCH; however, the underlying molecular mechanisms remain unclear. Here, we show that the crystal structure of the TBC1D23 C-terminal domain adopts a Pleckstrin homology domain fold and selectively binds to phosphoinositides, in particular, PtdIns(4)P, through one surface while binding FAM21 via the opposite surface. Mutation of key residues of TBC1D23 or FAM21 selectively disrupts the endosomal vesicular trafficking toward the Trans-Golgi Network. Finally, using the zebrafish model, we show that PCH patient-derived mutants, impacting either phosphoinositide binding or FAM21 binding, lead to abnormal neuronal growth and brain development. Taken together, our data provide a molecular basis for the interaction between TBC1D23 and FAM21, and suggest a plausible role for PtdIns(4)P in the TBC1D23-mediating endosome-to-TGN trafficking pathway. Defects in this trafficking pathway are, at least partially, responsible for the pathogenesis of certain types of PCH.Entities:
Keywords: Golgi; endosome; membrane trafficking; neuronal development; pontocerebellar hypoplasia
Mesh:
Substances:
Year: 2019 PMID: 31624125 PMCID: PMC6842616 DOI: 10.1073/pnas.1909316116
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205